Urinary biomarkers reporting weakness and validation failure in Type 2 diabetic nephropathy: systematic review

被引：1

作者：

Siddiqui, Khalid ^{[1
]}

Joy, Salini S. ^{[1
]}

Ilias, Shumaila ^{[1
]}

Alzeer, Haya S. ^{[3
]}

Al-Rubeaan, Khalid ^{[1
,2
]}

机构：

[1] King Saud Univ, Dept Biochem, Strateg Ctr Diabet Res, Riyadh, Saudi Arabia

[2] King Saud Univ, Univ Diabet Ctr, Coll Med, Riyadh, Saudi Arabia

[3] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia

来源：

BIOMARKERS IN MEDICINE | 2018年 / 12卷 / 05期

关键词：

diagnostic accuracy; markers; reporting quality; Type 2 diabetic nephropathy; urinary biomarkers; MONOCYTE CHEMOATTRACTANT PROTEIN-1; BETA-D-GLUCOSAMINIDASE; IV COLLAGEN; DIAGNOSTIC-ACCURACY; TUBULAR MARKERS; CYSTATIN C; RENAL INJURY; EARLY-STAGE; MELLITUS; ASSOCIATION;

D O I：

10.2217/bmm-2017-0338

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

For better identification of novel diagnostic urinary biomarker in Type 2 diabetic nephropathy (T2DN), methodological and reporting quality is as important as validity of biomarkers. The aim of this systematic review is to find out the best-reported diagnostic urinary biomarkers study in T2DN based on STARD criteria. We also analyzed the validity of urinary markers in the selected articles those followed STARD criteria. The diagnostic accuracy of urinary biomarkers on T2DN is not conclusive because of the poor reporting quality and differences in adjustment for conventional risk factors. For a proper validation of urinary biomarkers on T2DN, in future large well-designed longitudinal studies, with specific prediction analysis and validation of the biomarkers by adjusting with possible conventional risk factors.

引用

页码：487 / 499

页数：13

共 50 条

[1] Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
Temesgen Fiseha
Biomarker Research, 3 (1)
[2] Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
Fiseha, Temesgen
BIOMARKER RESEARCH, 2015, 3
[3] Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review
Karimi, Farzaneh
Moazamfard, Mostafa
Taghvaeefar, Rasul
Sohrabipour, Shahla
Dehghani, Aghdas
Azizi, Reza
Dinarvand, Negar
ADVANCED BIOMEDICAL RESEARCH, 2024, 13 (01):
[4] Urinary biomarkers in diabetic nephropathy
Soltani-Fard, Elahe
Taghvimi, Sina
Karimi, Farzaneh
Vahedi, Farzaneh
Khatami, Seyyed Hossein
Behrooj, Hamid
Hayati, Mojdeh Deylami
Movahedpour, Ahmad
Ghasemi, Hassan
CLINICA CHIMICA ACTA, 2024, 561
[5] The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
Zhang, Deyuan
Ye, Shandong
Pan, Tianrong
PEERJ, 2019, 7
[6] IDENTIFICATION OF URINARY MICRORNA BIOMARKERS FOR DIABETIC NEPHROPATHY
Beltrami, Cristina
Simpson, Kate A.
Jesky, Mark D.
Jenkins, Robert H.
Phillips, Aled O.
Satchell, Simon C.
Cockwell, Paul
Fraser, Donald J.
Bowen, Timothy
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
[7] Proteomic identification of urinary biomarkers of diabetic nephropathy
Rao, Paturi V.
Lu, Xinfang
Standley, Melissa
Pattee, Patrick
Neelima, Gundupalle
Girisesh, Gudige
Dakshinamurthy, K. V.
Roberts, Charles T., Jr.
Nagalla, Srinivasa R.
DIABETES CARE, 2007, 30 (03) : 629 - 637
[8] Urinary exosomes: Potential biomarkers for diabetic nephropathy
Sinha, Nisha
Kumar, Vivek
Puri, Veena
Nada, Ritambhra
Rastogi, Ashu
Jha, Vivekanand
Puri, Sanjeev
NEPHROLOGY, 2020, 25 (12) : 881 - 887
[9] Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy
Gluhovschi, Cristina
Gluhovschi, Gheorghe
Petrica, Ligia
Timar, Romulus
Velciov, Silvia
Ionita, Ioana
Kaycsa, Adriana
Timar, Bogdan
JOURNAL OF DIABETES RESEARCH, 2016, 2016
[10] Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy
Bakoush, O
Tencer, J
Tapia, J
Rippe, B
Torffvit, O
KIDNEY INTERNATIONAL, 2002, 61 (01) : 203 - 208

← 1 2 3 4 5 →